| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |